ATE348631T1 - Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen - Google Patents

Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Info

Publication number
ATE348631T1
ATE348631T1 AT02797695T AT02797695T ATE348631T1 AT E348631 T1 ATE348631 T1 AT E348631T1 AT 02797695 T AT02797695 T AT 02797695T AT 02797695 T AT02797695 T AT 02797695T AT E348631 T1 ATE348631 T1 AT E348631T1
Authority
AT
Austria
Prior art keywords
plasminogen
eartums
healing
relates
tympanic membrane
Prior art date
Application number
AT02797695T
Other languages
German (de)
English (en)
Inventor
Tor Ny
Jinan Li
Sten Hellstrom
Per-Olof Eriksson
Original Assignee
Omnio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnio Ab filed Critical Omnio Ab
Application granted granted Critical
Publication of ATE348631T1 publication Critical patent/ATE348631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Manufacture Of Motors, Generators (AREA)
AT02797695T 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen ATE348631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31764301P 2001-09-06 2001-09-06

Publications (1)

Publication Number Publication Date
ATE348631T1 true ATE348631T1 (de) 2007-01-15

Family

ID=23234611

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06126236T ATE552842T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung
AT02797695T ATE348631T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06126236T ATE552842T1 (de) 2001-09-06 2002-09-06 Verwendung von plasminogen zur wundheilung

Country Status (9)

Country Link
US (3) US7067492B2 (es)
EP (2) EP1427440B1 (es)
CN (2) CN1289145C (es)
AT (2) ATE552842T1 (es)
AU (1) AU2002361878A1 (es)
DE (1) DE60216939T2 (es)
DK (2) DK1790354T3 (es)
ES (2) ES2387797T3 (es)
WO (1) WO2003020297A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
EP1901789A2 (en) * 2005-06-30 2008-03-26 Anthrogenesis Corporation Repair of tympanic membrane using placenta derived collagen biofabric
EP2397852B1 (en) * 2006-03-14 2013-12-04 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
CA2662083C (en) 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
DK2056864T3 (en) 2006-08-28 2014-03-10 Omnio Healer Ab CANDIDATES AGAINST INFECTION
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
EP2664341A3 (en) 2006-10-06 2014-01-08 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
WO2008146224A2 (en) 2007-05-25 2008-12-04 Compex Medical S.A. Wound healing electrode set
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
WO2009093970A1 (en) * 2008-01-22 2009-07-30 Omnio Healer Ab Method of improving wound healing
RU2018146249A (ru) 2013-05-15 2019-01-18 Зе Боард Оф Трастиз Оф Зе Леланд Стэнфорд Джуниор Юниверсити Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
TWI801331B (zh) * 2015-11-03 2023-05-11 美商波麥堤克生物治療股份有限公司 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法
TW201722464A (zh) * 2015-11-10 2017-07-01 波麥堤克生化科學有限公司 用於傷口癒合之纖維蛋白溶酶原給藥方案
WO2017101870A1 (zh) * 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种预防或治疗糖尿病性视网膜病变的方法
US11090372B2 (en) 2015-12-18 2021-08-17 Talengen International Limited Method of treating diabetic nephropathy comprising administering plasminogen
US11400142B2 (en) 2015-12-18 2022-08-02 Talengen International Limited Treatment of diabetic nerve injury comprising administering plasminogen
CA3008186A1 (en) 2015-12-18 2017-06-22 Talengen International Limited Novel method for preventing and treating angiocardiopathy
WO2017101872A1 (zh) 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种用于预防和治疗宫颈糜烂的方法
CA3008466C (en) 2015-12-18 2023-06-20 Talengen International Limited Method for preventing or treating radiation and chemical damage
TWI674903B (zh) * 2016-09-26 2019-10-21 國立陽明大學 製備改良豬血漿纖連蛋白以增強傷口癒合之應用
WO2018108161A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法和药物
TWI734798B (zh) 2016-12-15 2021-08-01 大陸商深圳瑞健生命科學研究院有限公司 一種預防和治療肺纖維化的方法
CN110167583A (zh) 2016-12-15 2019-08-23 泰伦基国际有限公司 一种治疗冠状动脉粥样硬化及其并发症的方法
US11311607B2 (en) 2016-12-15 2022-04-26 Talengen International Limited Method for making glucagon and insulin restore normal balance
CN108210901A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 一种新的降血糖和提高糖耐量的药物
WO2018107707A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种改善心脏病变的方法
CN108210905A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 预防和治疗皮肤纤维化的药物及其用途
CN111344004A (zh) 2017-06-19 2020-06-26 泰伦基国际有限公司 一种调控glp-1/glp-1r 的方法和药物
EP4251195A1 (en) * 2020-11-25 2023-10-04 Grifols Worldwide Operations Limited Wound healing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013640A1 (en) * 1989-05-01 1990-11-15 The University Of Notre Dame Du Lac Methods and materials for expression of human plasminogen in a eukaryotic cell system
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
EP0723782B1 (en) 1995-01-27 2002-10-16 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Use of a preparation comprising a plasminogen activator to improve wound healing
EP0830381A4 (en) 1995-06-09 2000-11-22 William N Drohan CHITINE HYDROGELS, PRODUCTION METHOD AND USE
US6043407A (en) 1997-07-29 2000-03-28 Warner-Lambert Company Debridement pad
AU1731300A (en) * 1998-11-25 2000-06-13 Bristol-Myers Squibb Company Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
WO2000061179A1 (en) * 1999-04-14 2000-10-19 Karolinska Innovations Ab Kringle domains of plasminogen, capable of modulating angiogenesis in vivo
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme

Also Published As

Publication number Publication date
US20030147879A1 (en) 2003-08-07
US7067492B2 (en) 2006-06-27
ATE552842T1 (de) 2012-04-15
DK1790354T3 (da) 2012-07-23
DE60216939D1 (de) 2007-02-01
WO2003020297A3 (en) 2003-10-09
DK1427440T3 (da) 2007-04-30
US20070041962A1 (en) 2007-02-22
US20080090751A1 (en) 2008-04-17
CN1585649A (zh) 2005-02-23
CN1289145C (zh) 2006-12-13
DE60216939T2 (de) 2007-10-04
WO2003020297A2 (en) 2003-03-13
CN1961958B (zh) 2011-05-18
EP1427440A2 (en) 2004-06-16
EP1790354B1 (en) 2012-04-11
CN1961958A (zh) 2007-05-16
ES2279001T3 (es) 2007-08-16
EP1790354A2 (en) 2007-05-30
US8679482B2 (en) 2014-03-25
EP1427440B1 (en) 2006-12-20
WO2003020297A8 (en) 2004-07-08
AU2002361878A1 (en) 2003-03-18
US8637010B2 (en) 2014-01-28
ES2387797T3 (es) 2012-10-01
EP1790354A3 (en) 2007-10-24

Similar Documents

Publication Publication Date Title
ATE348631T1 (de) Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE60101669T2 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
DE60130008D1 (de) Proteinkombinationen zur heilung von wunden
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE402699T1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
ATE328606T1 (de) Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE50313329D1 (de) 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE314066T1 (de) Verwendung von buprenorphin zur therapie der harninkontinenz
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
ATE353666T1 (de) Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE450222T1 (de) Osteosyntheseplatte zur operativen versorgung von knochenfrakturen
ATE360437T1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1427440

Country of ref document: EP